NCT00332059View on ClinicalTrials.gov

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Ocular Hypertension
Interventions
DRUG

bimatoprost/timolol fixed combination

Trial Locations (4)

Unknown

Bel Air

Vienna

Montreal

Berlin

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00332059 - Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter